Bio Protocol vs The Graph — how do they compare? Bio Protocol trades at Rp443.23 (market cap Rp999,88M, Rp161,38M 24h volume), while The Graph trades at Rp242.61 (market cap Rp2,62T, Rp180,87M 24h volume). The key difference: The Graph is far larger — about 2620.3× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while The Graph's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and The Graph for 96 Days on average.
| BIO | GRT | |
|---|---|---|
Market Cap | Rp999,88M | Rp2,62T |
Volume (24h) | Rp161,38M | Rp180,87M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 10,9B GRT |
Typical Hold Time | 18 Days | 96 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
The Graph (GRT) is trading at Rp243.37 with a bearish technical outlook, showing oversold RSI conditions but strong selling pressure from moving averages. The token faces near-term resistance at Rp247 while finding support at Rp239. Market cap stands at Rp2.66 trillion with 10.9 million tokens circulating. Recent network activity shows steady protocol usage but limited major ecosystem updates.
Overall outlook remains cautious with potential for short-term rebounds from oversold levels, but broader bearish momentum persists. Key opportunities include protocol adoption growth, while risks involve crypto market volatility and regulatory uncertainty. Investors should monitor support levels and trading volume patterns closely.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →The Graph is a protocol for organizing blockchain data and making it easily accessible. It powers many of the most used applications in decentralized finance (DeFi) and the broader Web3 ecosystem today.
Read more on GRT →